NCT03203525 2026-02-25Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic CancerM.D. Anderson Cancer CenterPhase 1 Active not recruiting38 enrolled